Home > Quotes > PBYI

Puma Biotechnology Inc Common Stock Quote & Summary Data

Get PBYI Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading PBYI now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PBYI After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Puma Biotechnology Inc Common Stock Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 30.99 $ 212.429
Low $ 28.69 $ 25.20

The current last sale of $29.90 is 18.65% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Unless otherwise provided in this Annual Report, references to the "Company," "we," "us," and "our" refer to Puma Biotechnology, Inc., a Delaware corporation formed on April 27, 2007 and formerly known as Innovative Acquisitions Corp., together with its wholly-owned subsidiary, Puma Biotechnology Ltd., and all references to "Former Puma" refer to Puma Biotechnology, Inc., a privately-held Delaware corporation formed on September 15, 2010, that merged with and into us in October 2011. We refer to this transaction as the "Merger." We are a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. We in-license the global development and commercialization rights to three drug candidates--PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357.  ... More ...  

Risk Grade

Where does PBYI fit in the risk graph?

Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?